^
Contact us to learn more about
our Premium Content: News alerts, weekly reports and conference plannersDRUG:
EU307
i
Contact us to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Company:
Eutilex
Drug class:
GPC-3-targeted CAR-T immunotherapy, IL-18 stimulant
Related drugs:
Phase 1
Eutilex
Recruiting
Last update posted :
03/15/2024
Initiation :
08/24/2023
Primary completion :
06/01/2025
Completion :
12/01/2025
IFNG • IL6 • TNFA • GPC3 • IL2 • IL10 • IL18
|
EU307
Share
